Ovarian Cancer IMPACT Act Was Introduced
New legislation aims to expand insurance coverage for genetic testing and boost federal education on gynecologic cancer risks.
Updated on Sept. 29, 2026 in Cancer
Live Poll
Should insurance companies be legally required to cover more preventative genetic testing for cancer risks?
Lawmakers have introduced the Ovarian Cancer IMPACT Act, a bill that would require private insurance plans to cover genetic testing for individuals with hereditary risk factors. The legislation also seeks to improve early detection and prevention of gynecologic cancers by expanding federal education and outreach programs.
Why it matters
The bill aims to address long-standing disparities in access to specialized care and genetic screenings. By reauthorizing a 20-year-old CDC program, the legislation seeks to improve prevention strategies and early diagnosis for patients across the United States.
The proposed legislation mandates coverage for genetic cancer screenings and reauthorizes a 20-year-old CDC education campaign known as Johanna's Law. These measures are designed to address access barriers, though the ultimate clinical impact on cancer outcomes remains to be seen.
The players
Sen. Elissa Slotkin
A U.S. Senator from Michigan who has championed legislative efforts related to cancer care.
Sen. Katie Britt
A U.S. Senator from Alabama involved in the introduction of the proposed gynecologic cancer legislation.
CDC
The Centers for Disease Control and Prevention is the federal agency responsible for implementing health outreach programs like Johanna's Law.
The details
The Ovarian Cancer IMPACT Act functions by mandating that private insurance providers include genetic cancer screenings in their coverage, reducing out-of-pocket costs for those with hereditary risk. Additionally, the bill provides funding to revitalize a federal education campaign focused on the awareness and early detection of gynecologic cancers, a move intended to help patients recognize risks sooner.
Timeline
In 2011, Judith Slotkin passed away from ovarian cancer.
On September 29, 2026, the Ovarian Cancer IMPACT Act was introduced.
Health Landscape
This legislation marks a significant update to the foundational outreach established by Johanna's Law two decades ago. It reflects a broader shift toward integrating personalized genetic risk assessment into standard insurance-covered gynecologic care.
If you have a family history of gynecologic cancers, monitor this legislation for updates on how coverage for genetic testing may change for your insurance plan. Discuss your hereditary risk factors with your doctor to determine if current screening options are appropriate for your health history.
The takeaway
The proposed Ovarian Cancer IMPACT Act seeks to lower financial barriers to genetic screening and improve gynecologic cancer literacy. Patients concerned about their risk profile should maintain a conversation with their physician about existing testing options while awaiting further legislative updates.
Further reading
Learn more about the latest developments in Cancer screenings and prevention.
Source note: This article includes information reported by WLNS 6 Lansing.
Live Poll
Should insurance companies be legally required to cover more preventative genetic testing for cancer risks?
